Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

For the year, the company reported profit of $5.98 billion, or $25.68 per share. Revenue was reported as $175.2 billion. Elevance Health expects full-year earnings in the range of $34.15 to $34.85 per ...

Health-care companies rose sharply amid strong earnings.

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared.

The headline numbers for Elevance Health (ELV) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...

The company posted adjusted earnings per share of $3.84 for Q4 2024, falling short of the $3.98 consensus estimate. Revenue ...

Elevance Health reported nearly $6 billion in 2024 profits including $418 million in the fourth quarter as the health insurer ...

Reports Q4 revenue $45B, consensus $44.72B. “As part of our commitment to elevating whole health and advancing health beyond healthcare, we ...